Regulatory News
Monday, May 23, 2016
BRIEF-Allergan's botox wins Japanese approval to treat crow's feet lines
* Allergan's botox vista (botulinum toxin type a) receives
national marketing authorisation in japan for treatment of
crow's feet lines in adult patients
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment